Similar articles

• Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.

  Obayashi T, Negishi K, Suzuki T, Funata N. Obayashi T, et al. Clin Infect Dis. 2008 Jun 15;46(12):1864-70. doi: 10.1086/588295. Clin Infect Dis. 2008. PMID: 18462174
• [Problems and recent advances in measurement of (1-->3)-beta-D-glucan].

  Yoshida K, Shoji H, Niki Y. Yoshida K, et al. Nihon Ishinkin Gakkai Zasshi. 2008;49(2):75-80. doi: 10.3314/jjmm.49.75. Nihon Ishinkin Gakkai Zasshi. 2008. PMID: 18451587 Review. Japanese.
• Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients.

  Presterl E, Parschalk B, Bauer E, Lassnigg A, Hajdu S, Graninger W. Presterl E, et al. Int J Infect Dis. 2009 Nov;13(6):707-12. doi: 10.1016/j.ijid.2008.10.013. Epub 2009 Jan 20. Int J Infect Dis. 2009. PMID: 19157947
• [1,3-Beta-D-glucan measurement and its usefulness in the diagnosis of invasive fungal infections].

  Kocmanová I, Rácil Z, Koukalová D, Mayer J. Kocmanová I, et al. Klin Mikrobiol Infekc Lek. 2008 Jun;14(3):88-92. Klin Mikrobiol Infekc Lek. 2008. PMID: 18688768 Review. Czech.
• [Utility of galactomannan enzyme immunoassay and (1,3)beta-D-glucan assay in invasive fungal infection].

  Yu J, Li RY, Gao LJ, Lu QY, Wang XH. Yu J, et al. Zhonghua Yi Xue Za Zhi. 2010 Feb 9;90(6):371-4. Zhonghua Yi Xue Za Zhi. 2010. PMID: 20367931 Chinese.